* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : diagnosis;

Obsolete resource : false;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://www.inspq.qc.ca/publications/3597
2025
Canada
technical report
due to
bacillus
Point-of-Care Testing
gram-negative bacillus
laboratories
laboratory test, nos

---
https://cps.ca/fr/documents/position/mise-a-jour-sur-linfection-congenitale-a-cytomegalovirus-la-prevention-prenatale-le-diagnostic-neonatal-et-la-prise-en-charge
2025
false
false
false
Canada
guideline
prenatal care
congenital cytomegalovirus infection
prenatal diagnosis
cytomegalovirus infections
infection control
no diagnosis
Infectious disease

---
https://www.academie-medecine.fr/attention-au-contact-etroit-des-enfants-au-domicile-avec-des-animaux-de-compagnie-non-traditionnels-acnt-2/
2025
France
scientific and technical information
preventive treatment, nos
fibrosis, nos
secondary prevention
fibrosis
early therapy
early diagnosis
no diagnosis
kidney, nos

---
https://www.cmg.fr/wp-content/uploads/2025/01/Depistage-organise-des-cancers-CMG-Fiche-Patient-202409.pdf
2025
France
patient education handout
screening
organization
has patient
mass screening
patients

---
https://www.cmg.fr/wp-content/uploads/2025/01/Depistage-organise-Fiche-MG-202409.pdf
2025
France
scientific and technical information
general practitioners
organization
screening
general practice
mass screening

---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_1.html
2025
France
journal article
neoplasm, malignant
malignant neoplasm cervix
vaccination
france
screening
vaccination
uterine cervical neoplasms
french
mass screening
preventive immunization/medication
vaccination, nos
cancer of the uterine cervix

---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_2.html
2025
France
journal article
early detection of cancer
cancer of the uterine cervix
screening for cancer
Program
period analysis
organization
french
uterine cervical neoplasms
demography
mass screening
malignant neoplasm cervix
cancer screening
insurance coverage
france

---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_3.html
2025
France
journal article
cancer screening
breast neoplasms
mass screening
due to
screening for cancer
early detection of cancer
organization
french
Program
france
breast cancer

---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_5.html
2025
France
journal article
registers
mass screening
screening
evaluation studies as topic

---
https://www.has-sante.fr/jcms/p_3587389/fr/evaluation-de-la-pertinence-d-un-depistage-systematique-de-l-infection-a-cytomegalovirus-cmv-au-cours-de-la-grossesse-feuille-de-route
2025
France
public health guidelines
cytomegalovirus infection, nos
pregnancy, nos
cytomegalovirus infections
pregnancy
evaluation studies as topic
mass screening

---
https://cngof.fr/app/pdf/RPC//RPC%20DU%20CNGOF/Gyn%C3%A9cologie/Oncologie/Reco%20depistage%20col%20GOFS%202025.pdf?x60010
2025
France
consensus
dermatomyositis
screening
health planning guidelines
disease management
women
uterus, nos
viral disease other/nos
papillomaviridae
cell biology
Cytology
female
abnormal behavior, nos
mass screening

---
https://www.has-sante.fr/jcms/p_3591257/fr/surpoids-et-obesite-chez-la-femme-depistage-et-accompagnement
2025
France
practice guideline
overweight
obesity, nos
female
obesity
mass screening
screening
obesity
women

---
https://www.has-sante.fr/jcms/p_3591624/fr/sequencage-haut-debit-cible-des-panels-de-genes-dans-le-diagnostic-des-cardiomyopathies-hereditaires-rapport-d-evaluation
2025
France
health technology assessment
sequence analysis
evaluation studies as topic
diagnosis
genes
sequence determinations
evaluation report
cardiomyopathy, nos
albumin/globulin ratio
no diagnosis
cardiomyopathies

---
https://conseil-scientifique.public.lu/fr/publications/examens-laboratoire/conduite-a-tenir-devant-la-decouverte-fortuite-d-une-augmentation-de-la-creatininemie-lors-d-un-bilan-biologique-standard-en-medecine-generale.html
2025
Luxembourg
practice guideline
biologist (general)
telephone switchboard operator
incidental discovery
clinical chemistry tests
general practice
creatininemia
specimen handling
incidental findings
biology
reference standards
Balance Sheet
biology
disease management

---
https://www.canal-u.tv/chaines/ut2j/l-intelligence-methodes-pratiques-outils-et-objets-scientifiques-en-dialogue/l
2025
France
audiovisual aids
diagnosis
no diagnosis
diagnosis, computer-assisted
medical oncology
intelligence, nos
artificial intelligence
pathology
anatomic pathologist

---
https://www.sfmu.org/fr/vie-professionnelle/outils-professionnels/consensus//recommandations-relatives-aux-indications-de-l-utilisation-des-tests-quadriplex-virus-influenza-a-b-rsv-et-sars-cov-2-et-des-tests-multiplex-etendus-pour-le-diagnostic-des-viroses-respiratoires-dans-le-contexte-hospitalier-et-etablissement-de-soins/con_id/561
2025
France
guideline
hospital, nos
Off-Label use
virus diseases
indication of
nursing
viruses
suggestive of
diagnosis
hospitals
site of care, nos
influenza A virus
influenzavirus, nos
no diagnosis
SARS-CoV-2

---
https://www.has-sante.fr/jcms/p_3459735/fr/evaluation-des-strategies-de-depistage-et-de-reperage-precoce-de-la-tuberculose-pulmonaire
2025
France
public health guidelines
mass screening
respiratory tuberculosis
tuberculosis
tuberculosis, pulmonary
evaluation studies as topic
early medical intervention
screening
early diagnosis

---
https://www.has-sante.fr/jcms/p_3598771/fr/tuberculose-pulmonaire-structurer-le-depistage-et-le-reperage-precoce-dans-les-populations-a-risque
2025
France
scientific and technical information
early medical intervention
tuberculosis, pulmonary
risk assessment
tuberculosis
communication
population at risk
mass media
press releases
communism
respiratory tuberculosis
risk factors
screening
early diagnosis

---
https://www.cancer.fr/presse/depistage-des-cancers-du-poumon-et-vaccination-contre-les-cancers-hpv-l-institut-national-du-cancer-s-adresse-aux-medecins-generalistes-a-l-occas
2025
France
scientific and technical information
general practitioners
screening
papillomavirus vaccines
general practice
general physician, nos
lung
vaccination, nos
congresses as topic
vaccination
national cancer institute (U.S.)
institutes
mass screening
viral disease other/nos
preventive immunization/medication
cancer
vaccination
neoplasm, malignant

---
https://www.reseau-naissance.fr/medias/2025/03/RSN_PRO_022-depsitage-cardiopathie-sat-mater.pdf
2025
France
guideline
weights and measures
oximetry, pulse
motherhood
heart defects, congenital
hospitals, maternity
congenital abnormalities
developmental anomaly, nos
mass screening
screening
pulse, nos
oxygen analyzer
heart, nos
oximetry
measures

---
https://cms.cmq.org/files/documents/Avis-et-prises-de-position/avis-TCCL-CC-20250108.pdf
2025
Canada
scientific and technical information
diagnosis
therapeutics
sports activity, nos
concussion
no diagnosis
injury, nos
Return to Sport
sports
brain concussion

---
https://www.has-sante.fr/jcms/p_3598581/fr/flash-securite-patient-erreurs-diagnostiques-dans-les-services-des-urgences-diagnostic-manque-urgence-aggravee
2025
France
scientific and technical information
patient safety
emergency service, hospital
no diagnosis
Missed Diagnosis
emergencies
has patient
diagnostic services

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/prevention-dune-reaction-dhypersensibilite-aux-agents-de-contraste.html
2025
Canada
technical report
hypersensitivity
hypersensitivity reaction, nos
contrast media

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-disponibilite-de-tsoludose-solution-buvable-en-recipient-unidose
2025
false
false
false
France
French
drug information
thyroxine
levothyroxine sodium
administration, oral
pharmaceutical solutions
patients guideline
guideline

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/tsoludose-solution-buvable-en-recipient-unidose-levothyroxine
2025
false
false
false
France
French
pharmaceutical solutions
administration, oral
levothyroxine sodium
levothyroxine sodium
drug information

---
https://www.inspq.qc.ca/publications/3601
2025
Canada
technical report
screening
carbapenemase
hospitals, general
hospitals, special
Carbapenem-Resistant Enterobacteriaceae
carbapenemase
measures
suggestive of
mass screening
central
indication of
indicators and reagents
weights and measures
hospital, nos
nursing

---
http://beh.santepubliquefrance.fr/beh/2024/16-17/2024_16-17_4.html
2024
France
journal article
viruses
tooth, nos
motivation
patients
central
mass screening
screening
Balance Sheet
has patient
virus, nos

---
https://www.has-sante.fr/jcms/p_3302482/fr/trouble-du-neurodeveloppement/-tdah-diagnostic-et-interventions-therapeutiques-aupres-des-enfants-et-adolescents
2024
France
practice guideline
therapeutics
adolescent
attention deficit disorder with hyperactivity
diagnosis
child
child, nos
adolescence
no diagnosis
therapy, nos

---
https://minerva-ebp.be/FR/Analysis/877
2024
Belgium
critical appraisal or critical reading
diagnosis
prostatic neoplasms
no diagnosis
prostate cancer
prostate, nos
cancer screening
malignant neoplasm prostate
screening for cancer
early detection of cancer
magnetic resonance imaging, nos
role
magnetic resonance imaging

---
https://www.has-sante.fr/jcms/p_3545370/fr/examens-bases-sur-l-adn-libre-circulant-realises-dans-le-cadre-du-depistage-de-la-trisomie-21-opportunite-du-reperage-d-autres-anomalies-chromosomiques
2024
France
public health guidelines
chromosome aberrations
Cell-Free Nucleic Acids
trisomy
mass screening
deoxyribonucleic acid, nos
DNA
down syndrome
chromosomal disease, nos
achievement
screening
chromosomes

---
https://www.has-sante.fr/jcms/p_3367010/fr/depistage-prise-en-charge-et-suivi-des-personnes-potentiellement-surexposees-au-cadmium-du-fait-de-leur-lieu-de-residence
2024
France
practice guideline
screening
cadmium
living place, nos
persons
aftercare
cadmium, nos
mass screening

---
https://www.academie-medecine.fr/infection-congenitale-a-cmv-un-depistage-a-organiser-en-france/
2024
France
scientific and technical information
french
organization
cytomegalovirus infections
cytomegalovirus infection, nos
cytomegalovirus
france
mass screening
screening

---
https://www.has-sante.fr/jcms/p_3302482/fr/trouble-du-neurodeveloppement/tdah-diagnostic-et-interventions-therapeutiques-aupres-des-enfants-et-adolescents
2024
France
practice guideline
therapeutics
child
adolescence
child, nos
no diagnosis
diagnosis
therapy, nos
adolescent

---
https://www.has-sante.fr/jcms/p_3546280/fr/ultravist-iopromide-produit-de-contraste-iode
2024
false
false
false
France
iopromide
neoplasm staging
Tumor Size Measurement
breast neoplasms
evaluation of the transparency committee
iopromide
contrast media

---
https://www.has-sante.fr/jcms/p_3546286/fr/omnipaque-iohexol-produit-de-contraste-iode
2024
false
false
false
France
insurance, health, reimbursement
iohexol
breast neoplasms
Tumor Size Measurement
neoplasm staging
evaluation of the transparency committee
contrast media
iohexol

---
https://www.has-sante.fr/jcms/p_3550669/fr/diagnostic-et-prise-en-charge-de-la-maladie-coeliaque-chez-l-enfant-et-l-adulte-note-de-cadrage
2024
France
practice guideline
disease management
celiac disease
child, nos
adult disease, nos
celiac disease
diagnosis
adult
adult children
no diagnosis
child

---
https://www.acadpharm.org/dos_public/COMMUNIQUE_MALADIES_RENALES_CHRONIQUES_VF.PDF
2024
France
guideline
chronic renal failure syndrome, nos
end-stage
screening
renal insufficiency, chronic
kidney failure, chronic
mass screening
health planning guidelines

---
https://www.has-sante.fr/jcms/p_3554605/fr/elucirem-gadopiclenol-diagnostic
2024
false
false
false
France
gadopiclenol
contrast media
insurance, health, reimbursement
adult
child
magnetic resonance imaging
cerebrum
cerebrum
liver
liver
kidney
kidney
pancreas
pancreas
lung
lung
prostate
prostate
breast
breast
blood-brain barrier
musculoskeletal system
musculoskeletal system
evaluation of the transparency committee
gadopiclenol

---
https://www.has-sante.fr/jcms/p_3554609/fr/vueway-gadopiclenol-diagnostic
2024
false
false
false
France
insurance, health, reimbursement
contrast media
gadopiclenol
adult
child
magnetic resonance imaging
blood-brain barrier
central nervous system
central nervous system
liver
liver
kidney
kidney
pancreas
pancreas
breast
breast
lung
lung
prostate
prostate
musculoskeletal system
musculoskeletal system
evaluation of the transparency committee
gadopiclenol

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1398
2024
France
public health guidelines
motivation
weights and measures
contraindication to
breast
screening
Contraindications
decreased motivation
virus, nos
european union
motivation, nos
donors
measures
waiting lists
transitory
seasons
tissue donors
west nile virus
albumin/globulin ratio
mass screening
research report

---
https://publications.msss.gouv.qc.ca/msss/document-001121/
2024
false
false
false
Canada
patient education handout
mass screening
mammography
Medical Examination
Examination
Additional Information Report
screening mammography
screening
Review
Screening Mammography

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1367
2024
France
public health guidelines
mass screening
Trial Screening
Pregnancy
Eligibility Determination
pregnancy
Last Screening
pregnancy complications, infectious
Substance Screening
cytomegalovirus infections
Cytomegaloviral Infection
Cancer Screening
Genetic Screening
Screening Study
Site Screening
cytomegalovirus infection, nos
pregnancy, nos
Pregnant
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-du-diabete-de-type-2-et-evaluation-du-risque-cardiovasculaire.html
2024
Canada
technical report
Cardiovascular Risk
Last Screening
Eligibility Determination
Genetic Screening
Trial Screening
Health Risk Assessment
Murine Cardiovascular System
Type 2 Diabetes Mellitus
Site Screening
Cancer Screening
mass screening
diabetes non-insulin dependent
screening for diabetes
screening
risk assessment
diabetes mellitus, type 2
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Screening Study
Cardiovascular
Cardiovascular System
cardiovascular risk
Substance Screening

---
https://www.ors-na.org/publications/diagnostic-sante-social-cls-la-rochefoucauld-porte-du-perigord/
2024
France
technical report
health communication
Disease or Disorder
Diagnosis Study
residence characteristics
Feel Worn Out
socialism
Health Communication
diagnosis
no diagnosis
community
Diagnosis Code
Social
Date of Diagnosis

---
https://www.canada.ca/fr/sante-publique/services/vih-sida/guide-depistage-diagnostic-infection-vih.html
2024
Canada
guideline
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Substance Screening
HIV Infection
viruses
hiv infections
Cancer Screening
no diagnosis
mass screening
HIV Infection Diagnosis
human immunodeficiency virus infection, nos
HIV
screening
Screening Study
Last Screening
humans
Guide Device
Human Immunodeficiency Virus
Eligibility Determination
human immunodeficiency virus, nos
Handbook
Genetic Screening
Date of Diagnosis
Diagnosis Study
Trial Screening
Site Screening
Diagnosis Code

---
https://www.cmg.fr/wp-content/uploads/2024/02/Le-depistage-cutane-CMG2024.pdf
2024
France
patient education handout
Substance Screening
Trial Screening
Cancer Screening
skin, nos
Screening Study
Site Screening
Last Screening
mass screening
screening
Cutaneous
Genetic Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Eligibility Determination
Cutaneous Route of Administration

---
https://www.cochrane.org/fr/CD001431/COMMUN_les-outils-daide-la-decision-pour-les-patients-confrontes-des-decisions-relatives-un-traitement
2024
United Kingdom
review of literature
french abstract
tool, nos
Substance Screening
Decision Aid
Tool
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Site Screening
Screening Study
has patient
decision support techniques
Last Screening
mass screening
screening
operations research
Medically Treated Reflux
Genetic Screening
decision aids
Patient
Cancer Screening
A^y/a
patients
Eligibility Determination
Trial Screening
Scientific Equipment

---
https://www.has-sante.fr/jcms/p_3497035/fr/iopamiron-iopamidol-produit-de-contraste-iode
2024
false
false
false
France
iopamidol
evaluation of the transparency committee
Iopamidol
iodine, nos
iopamidol
contrast media
iodine

---
https://www.has-sante.fr/jcms/p_3497041/fr/dotarem-acide-gadoterique-produit-de-contraste-pour-imagerie-par-resonnance-magnetique
2024
false
false
false
France
evaluation of the transparency committee
Gadoteric Acid
contrast media
magnetic resonance imaging

---
https://www.has-sante.fr/jcms/p_3497017/fr/omnipaque-iohexol-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iodine
omnipaque
contrast media
iohexol

---
https://www.has-sante.fr/jcms/p_3497062/fr/iomeron-iomeprol-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iodine, nos
iomeprol
contrast media
iomeprol
Iomeprol
iomeron
iomeprol
iodine

---
https://www.has-sante.fr/jcms/p_3497065/fr/visipaque-iodixanol-produit-de-contraste-iode
2024
false
false
false
France
iodixanol
-
-
evaluation of the transparency committee
iodine
iodixanol
contrast media

---
https://www.has-sante.fr/jcms/p_3497029/fr/xenetix-iobitridol-produit-de-contraste-iode
2024
false
false
false
France
iobitridol
evaluation of the transparency committee
contrast media
iodine
iobitridol

---
https://www.has-sante.fr/jcms/p_3497038/fr/optiray-ioversol-produit-de-contraste-iode
2024
false
false
false
France
ioversol
evaluation of the transparency committee
iodine
ioversol
contrast media

---
http://beh.santepubliquefrance.fr/beh/2024/5/2024_5_1.html
2024
France
journal article
Convenient
france
French Language
Program
french
Screening for Colorectal Cancer
organization
cancer screening
Schedule
malignant neoplasm colon/rectum
screening for cancer
early detection of cancer
French Catheter Gauge
Organization
Participation
Respect
Scheduled
Colorectal Cancer
Version
appraiser
colorectal neoplasms
mass screening
Estimate
Statistical Estimation

---
http://beh.santepubliquefrance.fr/beh/2024/5/2024_5_2.html
2024
France
journal article
malignant neoplasm cervix
Program
Cervical Carcinoma
cancer of the uterine cervix
organization
National Cancer Program
screening for cancer
Convenient
Electronic System Deployment
cancer screening
Cervical Cancer Screening
mass screening
french
Cervical Cancer pT1a1 TNM Finding v8
early detection of cancer
uterine cervical neoplasms
What Month is it
france
CHFR Gene
Organization

---
https://minerva-ebp.be/FR/Article/2362
2024
Belgium
critical appraisal or critical reading
TNFRSF13C wt Allele
sphygmomanometers
Study Outcome Measure Description
blood pressure determination
What Month is it
Influence
Blood Pressure
resulting in
blood pressure, nos

---
https://www.health.belgium.be/fr/avis-9803-infections-sanguines-liees-aux-catheters
2024
Belgium
technical report
Infectious Disease Epidemiology
infectious disease, nos
Date of Diagnosis
Intravascular Route of Administration
Infection
Diagnosis Study
no diagnosis
Dental Epidemiology
Genetic Epidemiology
lumen of blood vessel
Occupational Epidemiology
diagnosis
epidemiology
Tobacco Use Epidemiology
Breast Cancer Epidemiology
AIDS Epidemiology
Diagnosis Code
Catheter-Related infections
Catheterization
Disease or Disorder

---
https://iris.who.int/handle/10665/375979
2024
Switzerland
public health guidelines
Point-of-Care Testing
epidemics
orientation, nos
Laboratory Test Time
laboratory test, nos
no diagnosis
Application Context
orientation
Epidemic Disorder
CDISC Provisional Standard
Referring
laboratories
diphtheria
disease outbreaks
diphtheria, nos
Referral
Interim
Diphtheria
Date of Diagnosis
Orientation
Diagnosis Study
Montreal Cognitive Assessment Orientation Test
Laboratory Procedure
Direction
Diagnosis Code
diagnosis
CDISC ADAS-Cog - Orientation Summary Score

---
https://iris.who.int/handle/10665/376140
2024
Switzerland
scientific and technical information
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Diastolic Blood Pressure
Diabetes Mellitus
Cancer Screening
Antigua and Barbuda
Trial Screening
screening
Engaged
Eligibility Determination
screening for diabetes
Substance Screening
Improved
serbia
quality improvement
Enhance
Screening Study
registries
diabetes mellitus
Involvement
prejudice
Twenty Eight
Site Screening
Notification
mass screening
Last Screening
Have Diabetes
Genetic Screening
Propofol Infusion Syndrome
November

---
https://www.has-sante.fr/jcms/p_3498747/fr/radelumin-18f-psma-1007-cancer-de-la-prostate
2024
false
false
false
France
radiopharmaceuticals
insurance, health, reimbursement
Positron-Emission tomography
neoplasm staging
Prostate-Specific antigen
PSMA-1007 (18F)
evaluation of the transparency committee
prostatic neoplasms
PSMA-1007
Fluorine-18

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/soins-de-plaies-evaluation-prise-en-charge-et-usage-optimal-des-traitements.html
2024
false
false
false
Canada
technical report
clinical tool
patient care management
evaluation studies as topic
wounds and injuries
wounds
nursing

---
https://ansm.sante.fr/tableau-marr/ranibizumab
2024
false
false
false
France
French
risk management
Ranibizumab
Ranibizumab
patients guideline
intravitreal injections
patient education handout
package leaflet
ranibizumab

---
https://ansm.sante.fr/tableau-marr/romiplostim
2024
false
false
false
France
French
injections, subcutaneous
romiplostim
risk management
romiplostim
guidelines for drug use
child
adult
patients guideline
clinical tool
home nursing
drug dosage calculations
self administration
receptors, fc
recombinant fusion proteins
thrombopoietin

---
https://publications.msss.gouv.qc.ca/msss/document-002818/
2024
false
false
false
Canada
public health guidelines
screening
Program
prenatal programming
prenatal diagnosis
embryonic and fetal development
mass screening

---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101217/n/validation-questionnaire-depistage-asthme-travail-qdart-l-tm-
2024
Canada
technical report
detective
asthma
mass screening
work
asthma, nos
questionnaires
screening
early diagnosis
occupation, nos
asthma

---
https://www.sfed.org/media/guide-pratique-ecolo-endoscopie-fiche-n10/
2024
France
scientific and technical information
endoscopy
research
endoscopes
endoscopy, nos
endoscope, nos

---
https://www.cochrane.org/fr/CD015522/EYES_lintelligence-artificielle-ia-est-elle-meilleure-que-lhomme-pour-diagnostiquer-la-degenerescence
2024
United Kingdom
review of literature
french abstract
macular degeneration
artificial intelligence
macule, nos
diagnosis
intelligence, nos
Age-Related Macular Degeneration
elderly man
macular degeneration
humans
wet macular degeneration

---
https://www.has-sante.fr/jcms/p_3555106/fr/les-erreurs-diagnostiques-en-medecine
2024
France
technical report
state medicine
diagnostic errors

---
https://ansm.sante.fr/tableau-marr/paracetamol
2024
false
false
false
France
French
risk management
acetaminophen
infusions, intravenous
guidelines for drug use
clinical tool

---
https://minerva-ebp.be/FR/Article/2405
2024
Belgium
critical appraisal or critical reading
risk
hypersensitivity
penicillins
Clinical Decision-Making
allergy to penicillin
penicillin
risk assessment

---
https://orscreainormandie.org/nos_derniers_travaux/le-diagnostic-regional-de-cancerologie-en-normandie-un-nouvel-outil-pour-la-sante-publique-regionale/
2024
France
scientific and technical information
diagnosis
no diagnosis
medical oncology

---
https://orbi.uliege.be/handle/2268/324376
2024
Belgium
technical report
retinopathy
diabetic retinopathy
screening
eye
mass screening
diabetic retinopathy, nos
screening for diabetes

---
https://dumas.ccsd.cnrs.fr/dumas-04690152
2024
France
dissertations, academic
depression, nos
depression
face
stalking
depressive disorder
adolescent
adolescence
general practitioners
mass screening
screening

---
https://dumas.ccsd.cnrs.fr/dumas-04714686
2024
France
dissertations, academic
mass screening
community health centers
health
screening
Neurodevelopmental Disorders

---
https://sante.gouv.fr/prevention-en-sante/sante-des-populations/enfants/article/depistages-et-prevention-chez-l-enfant
2024
France
popular works
scientific and technical information
screening
mass screening
child, nos
child

---
http://beh.santepubliquefrance.fr/beh/2024/23-24/2024_23-24_1.html
2024
France
journal article
men
Self-Testing
human immunodeficiency virus, nos
france
french
screening
homosexuality, male
Direct-To-Consumer Screening and Testing
mass screening
HIV

---
http://beh.santepubliquefrance.fr/beh/2024/23-24/2024_23-24_4.html
2024
France
journal article
mass screening
strawberry
devices
Set, Psychology
HIV
device, nos
screening
equipment and supplies
prescription fees
human immunodeficiency virus, nos

---
https://www.ssmg.be/wp-content/uploads/RMG/414/RMG414_21-23.pdf
2024
Belgium
journal article
health services needs and demand
early diagnosis
detective
needs
physicians
spouse abuse
adolescent

---
https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/Fr/89_Prevention__depistage_et_traitement_de_la_maladie_de_Chagas_congenitale_F.pdf
2024
Switzerland
consensus
preventive treatment, nos
mass screening
screening
infection by trypanosoma cruzi
expert testimony
expert opinion
chagas disease
congenital disease, nos

---
https://www.has-sante.fr/jcms/p_3563547/fr/depistage-de-la-tuberculose-latente-via-un-test-de-detection-de-la-production-d-interferon-gamma-igra-avant-initiation-d-un-traitement-par-un-medicament-de-la-classe-des-anti-jak-dont-sotyktu-deucravacitinib
2024
France
health technology assessment
drug therapy
tuberculosis, nos
production
filing
deucravacitinib
latent tuberculosis
interferon-gamma release tests
screening
economics
gamma interferon
interferon-gamma
deucravacitinib
Janus Kinase Inhibitors
detective
drug, nos
mass screening
tuberculosis
dermatomyositis

---
https://www.santepubliquefrance.fr/regions/provence-alpes-cote-d-azur-et-corse/documents/enquetes-etudes/2024/resultats-de-l-enquete-transversale-initiale-du-projet-13-en-sante-de-mediation-en-sante-aupres-des-populations-vulnerables-de-marseille.-conna
2024
France
technical report
viral disease other/nos
acquaintance
mediating
screening
health knowledge, attitudes, practice
health surveys
negotiating
vaccination, nos
detective
papillomavirus vaccines
Population Health
resulting in
posture, nos
colorectal neoplasms
transverse
vulnerable populations
insight, nos
breast
cross-sectional studies
vaccination
preventive immunization/medication
mass screening
vaccination
baseline survey

---
https://publications.msss.gouv.qc.ca/msss/document-003776/
2024
Canada
public health guidelines
evaluation studies as topic
Neurodevelopmental Disorders
working diagnosis
disturbance of orientation, nos
orientation
diagnosis

---
https://www.cochrane.org/fr/CD014839/RENAL_pourquoi-est-il-important-dameliorer-le-diagnostic-de-la-nephropathie-associee-au-polyomavirus-bk
2024
United Kingdom
review of literature
french abstract
kidney disease, nos
polyomavirus, nos
no diagnosis
kidney diseases
diagnosis
BK virus
polyomavirus

---
https://www.cochrane.org/fr/CD014780/CENTRALED_quelle-est-la-precision-des-differents-types-de-prelevements-pour-diagnostiquer-linfection-par-la
2024
United Kingdom
review of literature
french abstract
diagnosis
COVID-19
infectious disease, nos

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Ordonnances_collectives/Aide-Memoire_GAP_Depistage_maladies_chroniques_NON_DYN_Vfinale.pdf
2024
Canada
algorithms
chronically ill
memory, nos
screening
memory
chronic disease, nos
mass screening
sexually transmitted diseases
chronic disease

---
https://www.chu-lyon.fr/depistage-trisomie-21-au-cours-de-la-grossesse-marqueurs-seriques
2024
France
popular works
Biomarkers
mass screening
trisomy
pregnancy, nos
pregnancy
serum markers
screening
down syndrome

---
https://www.cancer.fr/catalogue-des-publications/melanomes-cutanes-du-diagnostic-au-suivi
2024
France
scientific and technical information
melanoma, cutaneous malignant
diagnosis
no diagnosis
skin, nos
aftercare
melanoma

---
https://www.has-sante.fr/jcms/p_3498744/fr/pylclari-18f-piflufolastat-cancer-de-la-prostate
2024
false
false
false
France
adult
radiopharmaceuticals
Positron-Emission tomography
F-18 DCFPyL PSMA Positron Emission Tomography
piflufolastat (18F)
Prostate-Specific antigen
neoplasm staging
neoplasm recurrence, local
injections, intravenous
evaluation of the transparency committee
prostatic neoplasms
Fluorine F 18 Piflufolastat
Fluorine-18

---
https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000049232368
2024
false
false
false
France
French
contrast media
insurance, health, reimbursement
legislation

---
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/PNDS%20Lupus%202024.pdf
2024
France
practice guideline
Legal Adult
no diagnosis
Child Individual
Diagnosis Code
adult
child, nos
adult children
Clinical Study Protocol
Software Maintenance
Systemic Immunotherapy
Date of Diagnosis
Child Relation
diagnosis
Day Care, Medical
On Study
adulthood
Update
Daycare
Diagnosis Study
Lupus Erythematosus
child

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/protocole-medical-national-initier-un-test-immunochimique-de-recherche-de-sang-occulte-dans-les-selles-ou-une-coloscopie-a-des-fins-de-depistage-ou-de-diagnostic-du-cancer-colorectal.html
2024
Canada
public health guidelines
Test Name
immunochemistry
colonoscopy
On Study
screening for cancer
dermatomyositis
Colorectal Cancer
Cancer Diagnosis
biomedical research
Laboratory Procedure
Screening Colonoscopy
Test Dosing Unit
Screening for Colorectal Cancer
cancer screening
malignant neoplasm colon/rectum
early detection of cancer
Initiation
diagnosis
no diagnosis
Fecal Occult Blood Test
Blood Products Laboratory Testing
feces
screening for occult blood in feces
Clinical Study Protocol
medical research
colorectal neoplasms
occult blood

---
https://www.ema.europa.eu/en/medicines/human/EPAR/vueway
2024
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
gadopiclenol
contrast media
gadopiclenol
drug approval
europe
gadopiclenol
magnetic resonance imaging
adult
child
product surveillance, postmarketing
central nervous system
liver
kidney
pancreas
lung
prostate
breast
musculoskeletal system
Gadolinium Enhancement
injections, intravenous
pregnancy
breast feeding

---
https://www.ema.europa.eu/en/medicines/human/EPAR/elucirem
2024
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
contrast media
gadopiclenol
gadopiclenol
drug approval
europe
adult
child
adolescent
magnetic resonance imaging
risk management
product surveillance, postmarketing
blood-brain barrier
liver
kidney
pancreas
lung
prostate
breast
musculoskeletal system

---
https://www.has-sante.fr/jcms/p_3500935/fr/gadovist-gadobutrol-produit-de-contraste-en-irm
2024
false
false
false
France
insurance, health, reimbursement
gadobutrol
evaluation of the transparency committee
gadobutrol
magnetic resonance imaging
contrast media

---
https://www.has-sante.fr/jcms/p_3500938/fr/ultravist-iopromide-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iopromide
iodine
contrast media

---
https://beh.santepubliquefrance.fr/beh/2024/6-7/2024_6-7_3.html
2024
France
journal article
Eligibility Determination
CHFR Gene
screening
Replacement
Relocation
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
ukraine
Other Agency or Organization
Balance Sheet
Screening Study
tuberculosis
organization
tuberculosis, nos
france
Tuberculosis
Checkup
Organization
tuberculosis
Cancer Screening
Site Screening
Trial Screening
Reposition
mass screening
Substance Screening
Last Screening
Genetic Screening
Organization Name
french

---
https://beh.santepubliquefrance.fr/beh/2024/6-7/2024_6-7_5.html
2024
France
journal article
Tuberculosis
disease, nos
No Evidence of Coronary Artery Disease
COVID-19 Infection
Disease Free
COVID-19
study characteristics
snacks
tuberculosis
pandemics
Case Series
How True Feel Bushed Right Now
Oral Cavity
Case Study
Butcher
diagnosis
Disease Steps Clinical Classification
tuberculosis, nos
mouth diseases
Disease Object
Nothing by Mouth
Diagnosis Study
tuberculosis, oral
Baking
data collection
Characteristic
Pandemic Disorder
tuberculosis
Murine Mouth
case study
Delight

---
https://www.cochrane.org/fr/CD013199/EYES_quelle-est-lutilite-de-lechographie-pour-le-diagnostic-de-larterite-cellules-geantes
2024
United Kingdom
review of literature
french abstract
Temporal Arteritis
Useful
Diagnosis Study
diagnosis, ultrasonic
ultrasonography
ultrasonography, nos
Ultrasonogram
no diagnosis
Exposure as Collected Occurrence
Ultrasound Mode
Diagnosis Code
giant cell arteritis
Date of Diagnosis
What Month is it
giant cell arteritis
Ultrasound Imaging
Ultrasound

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/reperage-et-diagnostic-de-la-rougeole.html
2024
Canada
practice guideline
Measles
diagnosis
measles
Date of Diagnosis
Diagnosis Code
measles
measles
Diagnosis Study
Tracking
Spotting
no diagnosis

---
http://beh.santepubliquefrance.fr/beh/2024/6-7/2024_6-7_3.html
2024
France
journal article
Substance Screening
Screening Study
french
Organization
Tuberculosis
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Relocation
france
Genetic Screening
Other Agency or Organization
mass screening
organization
Cancer Screening
Trial Screening
CHFR Gene
ukraine
tuberculosis
Site Screening
Replacement
Checkup
screening
tuberculosis, nos
Balance Sheet
Last Screening
tuberculosis
Reposition
Eligibility Determination
Organization Name

---
http://beh.santepubliquefrance.fr/beh/2024/6-7/2024_6-7_5.html
2024
France
journal article
tuberculosis, oral
Tuberculosis
pandemics
COVID-19 Infection
Nothing by Mouth
Pandemic Disorder
tuberculosis
EWS Disease Characteristics Table
disease attributes
Butcher
data collection
COVID-19
AML Disease Characteristics Table
study characteristics
tuberculosis, nos
Oral Cavity
diagnosis
mouth diseases
disease, nos
How True Feel Bushed Right Now
Murine Mouth
Delight
Diagnosis Study
Baking
tuberculosis

---
https://conseil-scientifique.public.lu/fr/publications/examens-laboratoire/osteoporose-2023.html
2024
Luxembourg
guideline
osteoporosis
Diagnosis Study
Fracture
osteoporosis
diagnosis
osteoporosis, nos
Diagnosis Code
risk assessment
fracture, nos
Charge
Fracture of Device/Material
osteoporotic fractures
no diagnosis
CDISC SDTM Protocol Risk Assessment Response Codelist
patient care management
Date of Diagnosis
Osteoporosis
Health Risk Assessment
risk-taking

---
https://www.has-sante.fr/jcms/p_3514977/fr/conduite-diagnostique-et-strategie-therapeutique-de-la-fibromyalgie-note-de-cadrage
2024
France
practice guideline
Therapeutic
professional practice
Driving
Fibromyalgia
Desmosine
Professional Practice
fibromyalgia
Have Not Been Diagnosed
therapeutics
fibromyositis, nos
diagnosis
Diagnosis
Treatment
Strategy
leadership
Therapeutic Procedure

---
https://www.rp2s.fr/wp-content/uploads/2024_Diabete-gestationnel_VDef.pdf
https://www.rp2s.fr/wp-content/uploads/2024_DG_Annexe1_Depistage.pdf
https://www.rp2s.fr/wp-content/uploads/2024_DG_Annexe2_Grossesse.pdf
https://www.rp2s.fr/wp-content/uploads/2024_DG_Annexe3_Accouchement.pdf
2024
France
guideline
Cancer Screening
screening
patient care management
Gestational Diabetes
mass screening
Substance Screening
Genetic Screening
Last Screening
Site Screening
Screening Study
diabetes, gestational
Trial Screening
screening for diabetes
Charge
Eligibility Determination
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening

---
https://www.hgr-css.be/fr/avis/9575/candida-auris
2024
Belgium
public health guidelines
health facilities
Established
Diagnosis Code
Preventive Intervention
Prevention Study
infection control
Management Occupations
diagnosis
Date of Diagnosis
Management
candida, nos
Disease or Disorder
health facility administration
Candida auris
Candida
Infection
Diagnosis Study
no diagnosis
infectious disease, nos
Prevention

---
https://www.rp2s.fr/wp-content/uploads/2024_RCIU_20juin.pdf
2024
France
practice guideline
disease management
Pediatric Failure to Thrive
Delay to Diagnosis due to Device
no diagnosis
Gross Motor Delay
prenatal diagnosis
Growth Retardation
growth delay
fetal growth retardation, nos
delayed diagnosis
Patient Observation
fetal growth retardation
Intrauterine

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2024-50/numero-6-juin-2024/depistage-sras-cov-2-infection-taux-vaccination-travailleurs-essentiels-non-soignants.html
2024
Canada
journal article
ATRX Mutation Analysis Was Not Performed
vaccination
First Degree Family History of Primary Brain Tumor Negative
Tumor Progression Absent After Initial Treatment
Has No Sibling
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant I-131 Therapy Negative
No History of Non-Cardiac Surgery
Adjuvant Post-operative Immunological Therapy Was Not Administered
Additional Molecular Studies Were Not Performed
Chemotherapy Not Received
Infection
ROS1 Rearrangement Analysis Was Not Performed
Genetic Screening
Intercurrent Illness is Absent at Onset of Chief Complaint
Severe Acute Respiratory Syndrome
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Norway
No History of Gestational Complication
Preoperative IV Antiemetics were not Administered
Other Preoperative IV Medications were not Administered
No Response to Intervention for Kawasaki Disease
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
mass screening
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Nitric Oxide Measurement
History of Medical Treatment Absent
EGFR Amplification Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Any Metastatic Diagnosis Absent
Characteristic
Preoperative IV Antacids were not Administered
Minor Criteria for Rheumatic Heart Disease Not Present
Lymph Node Dissection Was Not Performed
PTEN Mutation Analysis Was Not Performed
preventive immunization/medication
Fluorescence In Situ Hybridization Was Not Performed
Preoperative IV Opiates were not Administered
Neither Case or Control Status
ERBB2 Mutation Analysis Was Not Performed
SARS Coronavirus
Routine Cytogenetics Were not Completed
SDH Complex Mutation Analysis Was Not Performed
Severe acute respiratory syndrome-related coronavirus
screening
First Degree Family History Cancer Negative
Trial Screening
Caffeine Not Routinely Consumed
Radiation History Negative
Evidence of Disease Absent after Completion of Therapy
ATRX Gene Mutation Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
TP53 Mutation Analysis Was Not Performed
vaccination
No History of Congenital Heart Disease
Additional Immunohistochemistry Was Not Performed
BRAF Rearrangement Analysis Was Not Performed
Screening Study
Chief Complaint Not Caused by Trauma
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Radiation Therapy Not Received
Site Screening
Documentation Absent
Patient was Not Previously Evaluated for Current Chief Complaint
BRAF Mutation Analysis Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
MGMT Promoter Methylation Testing Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
1p/19q Deletion Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
Preoperative IV Sedation was Not Administered
Chief Complaint was Not Witnessed
Substance Screening
NF1 Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Unemployed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Regional Anesthesia was not Administered
Adjuvant Post-operative Chemotherapy Was Not Administered
New Disease is not Multifocal
MET Mutation Analysis Was Not Performed
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Paraneoplastic Syndrome is Not Present
RET Rearrangement Analysis Was Not Performed
No Known History of Alcohol Use
EGFR Gene Amplification Negative
Local Anesthesia Agents were not Administered
IDH Family Wildtype
Family History of Stomach Cancer Absent
IDH Family Mutation Analysis Was Not Performed
infectious disease, nos
Another Form of Birth Control was not Used
Cancer History Absent
History of Colorectal Cancer Negative
EGFR Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
No History of Rheumatic Fever
No History of Myopathy
Vaccination
10q23/PTEN Locus Deletion Analysis Was Not Performed
Last Screening
Use of Smokeless Tobacco at Time of Diagnosis Negative
Adverse Event Associated with Infection
Neither
No History of Neonatal Complication
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
caregivers
Eligibility Determination
New Tumor Event After Initial Treatment Absent
Not Lost to Follow-Up
PTEN Gene Mutation Negative
has provider
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
vaccination, nos
Physician Diagnosed Diabetes Absent
NON Mouse
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
NRAS Mutation Analysis Was Not Performed
Additional Surgery for New Tumor Event Absent
No Known History of Illicit Drug Use
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ALK Rearrangement Analysis Was Not Performed
IV Anesthesia was not Administered
Cancer Screening
Medication Not Taken
Patient was not Postmenopausal with no Prior Oophorectomy
Nitric Oxide
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
KIT Mutation Analysis Was Not Performed
Chemical/Occupational Exposure Absent
Tumor Reoccurrence Absent After Initial Treatment
Negation
No History of Kawasaki Disease
Hypertension Absent

---
https://dumas.ccsd.cnrs.fr/dumas-04549881
2024
France
dissertations, academic
pediatrician
Propranolol Hydrochloride
no diagnosis
pediatrics
disclosure
Overfill
What Month is it
parent, nos
Pediatric
overweight
Disease or Disorder
Pediatric
parents
Diagnosis Study
diagnosis
Diagnosis Code
Date of Diagnosis

---
https://dumas.ccsd.cnrs.fr/dumas-04609793
2024
France
dissertations, academic
health
Animal
no diagnosis
Safety Reporting Documentation
Animalia
What Month is it
disease, nos
Disease or Disorder
Overall Pooled Data
Date of Diagnosis
general practitioners
panthera uncia
KCNQ1 wt Allele
Generalized
diagnosis
Diagnosis Study
animals
animal diseases
One Health
animal, nos
Diagnosis Code

---
https://jefaismondepistage.e-cancer.fr/
2024
France
popular works
Screening Study
Eligibility Determination
Substance Screening
screening
Cancer Screening
Genetic Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Trial Screening
Site Screening
mass screening
Last Screening

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/aide-memoire-depistages-cancer-et-maladies-chroniques.html
2024
Canada
public health guidelines
Andorra
mass screening
Atherogenic Index of Plasma
Ethiopia
memory, nos
Acute Interstitial Pneumonia
memory
Disease Screening
Memory
Single-Stranded DNA Cytosine Deaminase
AH Receptor-Interacting Protein
With Some Help
AICDA wt Allele
AIP Gene
Assistance
Chronic Disease
screening
Docetaxel/Epirubicin Regimen
Endotracheal Route of Administration
Memory Device
chronically ill
chronic disease, nos
chronic disease
Without Help
Essential Thrombocythemia

---
https://www.sfdiabete.org/sites/www.sfdiabete.org/files/files/ressources/depistage_prise_en_charge_dt1.pdf
2024
France
practice guideline
Algeria
Last Screening
French Language
Position
Eligibility Determination
Gene Physical Location
Twelve
Substance Screening
Preclinical
french
consultants
Cancer Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Charge
Phase
patient care management
Site Screening
Type 1 Diabetes Mellitus
screening
French Catheter Gauge
Life Stage
mass screening
Trial Screening
CDISC SDTM Body Position Terminology
diabetes mellitus, type 1
france
screening for diabetes
Genetic Screening
Screening Study

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/croissance-developpement/depistages-lenfant
2024
France
educational course
Screening Study
mass screening
Genetic Screening
Last Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Child Relation
child
Trial Screening
Site Screening
Child Individual
child, nos
Cancer Screening
Substance Screening
Eligibility Determination
screening

---
https://www.reseau-naissance.fr/medias/2024/07/RSN-supplementation-vit-D-et-PEC-hypoca-2024.pdf
2024
France
guideline
Date of Diagnosis
health planning guidelines
Charge
diagnosis
hospitals, maternity
Diagnosis Code
Disease or Disorder
Newar Language
vitamin D
motherhood
no diagnosis
patient care management
Vitamin D Measurement
Hypocalcemia
Ergocalciferol
infant, newborn
hypocalcemia
newborn, nos
Nutritional Supplementation
hypocalcemia
New Lesion Identification
Diagnosis Study
vitamin d, nos
Human Papillomavirus-35
Thirty Five

---
http://beh.santepubliquefrance.fr/beh/2024/14/2024_14_1.html
2024
France
journal article
prophylactic treatment, nos
Socializing
Preventive Intervention
Eligibility Determination
Central Nervous System Prophylaxis
TRPM6 wt Allele
Social
Last Screening
Multiple Endocrine Neoplasia
PITRM1 wt Allele
mass screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Man
Mende Language
Screening Study
Reside
Cancer Screening
Pre-Exposure Prophylaxis
socialism
Exposure
Sexual Intercourse
Substance Screening
sexual exposure
geography
screening
Genetic Screening
Exposure Domain
Island
CHFR Gene
france
Isoleucine
coitus
men
Geography-Based Enrollment
sexual intercourse, nos
Site Screening
geographer
Isoleucine Measurement
french
Trial Screening
Prevention
Ivor Lewis Esophagectomy
ELL wt Allele
Geographic
Menogaril
Preparation
paris

---
http://www.eaclf.org/docs/TestADNlc-Notice_final.pdf
2024
France
patient education handout
Last Screening
information dissemination
pregnancy, nos
Destination
Circulating Cell-Free DNA
emigration and immigration
Informative
mass screening
Screening Study
Cytogenetic Abnormality
Substance Screening
Chromosome Disorder
Cell-Free DNA Blood Collection Tube
dna analysis, nos
DNA Analysis
chromosomal disease, nos
cfDNA Mutation
Informed
Pregnant People
DNA
Gravida
Genetic Screening
Cell-Free Nucleic Acids
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
chromosome analysis, nos
Cancer Screening
Trial Screening
Eligibility Determination
Site Screening
No Information Available
screening
chromosomes
chromosome aberrations
Oprelvekin

---
https://ansm.sante.fr/tableau-marr/paracetamol-iv
2024
false
false
false
France
French
acetaminophen
infusions, intravenous
administration, intravenous
-
guidelines for drug use
clinical tool
Wrong dose
medication errors

---
https://ansm.sante.fr/tableau-marr/paracetamol-iv-1
2024
false
false
false
France
French
acetaminophen
infusions, intravenous
administration, intravenous
guidelines for drug use
clinical tool
Wrong dose
medication errors

---
https://ansm.sante.fr/tableau-marr/paracetamol-iv-2
2024
false
false
false
France
French
acetaminophen
infusions, intravenous
administration, intravenous
guidelines for drug use
clinical tool
Wrong dose
medication errors

---
https://www.cfp.ca/content/70/7-8/e89
2024
Canada
journal article
Screening Study
Approach
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
infectious disease, nos
sexually transmitted diseases
Eligibility Determination
men
Last Screening
Menogaril
Multiple Endocrine Neoplasia
mass screening
Genetic Screening
coitus
Infections
Sexually Transmitted Disorder
Site Screening
Sexual Intercourse
Substance Screening
Man
screening
Trial Screening
sexual intercourse, nos
Cancer Screening
Mende Language
ELL wt Allele

---
https://www.has-sante.fr/jcms/p_3535602/fr/evaluation-de-la-pertinence-d-un-depistage-systematique-de-l-infection-a-cytomegalovirus-cmv-au-cours-de-la-grossesse-feuille-de-route
2024
France
public health guidelines
Assessment
Site Screening
Assessment
pregnancy, nos
mass screening
Genetic Screening
pregnancy
Protocol Treatment Course
Evaluation
Last Screening
Cancer Screening
cytomegalovirus infection, nos
Trial Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Screening Study
Pregnancy
Cytomegalovirus
Execution
Pregnant
cytomegalovirus infections
Physical Examination
Eligibility Determination
Substance Screening
evaluation studies as topic

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-dun-panel-multigene-diagnostique-pronostique-ou-predictif-pour-le-carcinome-pulmonaire-non-a-petites-cellules-par-biopsie-liquide.html
2024
Canada
health technology assessment
Percent of Predicted Value
Evaluation
Liquid Biopsy
Have Not Been Diagnosed
lung biopsy
Panel Device
biopsy, nos
lung, nos
carcinoma, non-small-cell lung
Diagnosis
Physical Examination
Prognostic
Assessment
liquid substance, nos
Lung Non-Small Cell Carcinoma
evaluation studies as topic
Liquid Biopsy
Assessment

---
https://ansm.sante.fr/actualites/pronostic-a-18-mois-des-cas-de-myocardite-attribuables-a-la-vaccination-arnm-contre-le-covid-19-le-jama-publie-les-resultats-dune-etude-de-pharmaco-epidemiologie-realisee-par-epi-phare
2024
false
false
false
France
French
drug information
COVID-19 Vaccines
mRNA Vaccines
myocarditis
myocarditis
Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)
prognosis
france
covid-19, RNA-based vaccine
COVID-19
mRNA COVID-19 Vaccine
cohort studies

---
https://monbilanprevention.sante.gouv.fr/
2024
false
false
false
France
preventive medicine
preventive health services
mass screening
adult
middle aged
aged
Healthy Lifestyle
popular works

---
https://www.has-sante.fr/jcms/p_3538936/fr/kaldenn-chlorure-de-rubidium-82rb-medicament-radiopharmaceutique
2024
false
false
false
France
radionuclide generators
rubidium (82Rb) chloride
Rubidium Chloride Rb-82
insurance, health, reimbursement
Positron emission tomography myocardial rest imaging using rubidium-82 (procedure)
Positron emission tomography myocardial stress imaging using rubidium-82 (procedure)
myocardium
Positron-Emission tomography
Myocardial Blood Flow
adult
coronary artery disease
evaluation of the transparency committee
rubidium
radiopharmaceuticals
rubidium chloride

---
http://beh.santepubliquefrance.fr/beh/2024/16-17/2024_16-17_1.html
2024
France
journal article
french
substance abuse treatment centers
hepatitis, viral, human
viral hepatitis
mass screening
screening
viral hepatitis, nos
france
human immunodeficiency virus, nos
hepatitis
Social Structure
viral structures
HIV

---
http://beh.santepubliquefrance.fr/beh/2024/16-17/2024_16-17_2.html
2024
France
journal article
mass screening
viral hepatitis, type a
geographic mapping
hepatitis D
Data Systems
france
french
screening
hepatitis A
health
delivery of health care

---
http://beh.santepubliquefrance.fr/beh/2024/16-17/2024_16-17_3.html
2024
France
journal article
no diagnosis
screening
diagnosis
mass screening
organization and administration

---
https://www.urofrance.org/2023/05/02/cystite-recidivante-du-depistage-a-la-prise-en-charge-optimale-2/
2023
France
scientific and technical information
cystitis, nos
Recidivism
cystitis
patient care management
recurrent
mass screening
Cystitis
screening

---
https://www.has-sante.fr/jcms/p_3428422/fr/locametz-gozetotide-cancer-de-la-prostate
2023
false
false
false
France
insurance, health, reimbursement
Gozetotide
Radiopharmaceutical Preparation Kit Dosage Form
gallium (68Ga) gozetotide
radiopharmaceuticals
gallium 68 PSMA-11
adult
Positron-Emission tomography
FOLH1 protein, human
evaluation of the transparency committee
prostatic neoplasms

---
https://www.has-sante.fr/jcms/p_3427910/fr/neuraceq-florbetabene-18f-maladie-d-alzheimer
2023
false
false
false
France
insurance, health, reimbursement
radiopharmaceuticals
injections, intravenous
Positron-Emission tomography
evaluation of the transparency committee
18F-florbetaben
alzheimer disease
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene

---
https://www.has-sante.fr/jcms/p_3432163/fr/artirem-acide-gadoterique-arthrographie-en-imagerie-par-resonance-magnetique
2023
false
false
false
France
insurance, health, reimbursement
gadolinium oxide
Magnetic resonance imaging arthrography (procedure)
gadoteric acid
Gadoteric Acid
evaluation of the transparency committee

---
http://nuxeo.edel.univ-poitiers.fr/nuxeo/site/esupversions/6604e3e9-c8e5-43c1-a936-7b216902481a
2023
France
screening
behavior disorders
Eating behavior disorders
Eating behavior disorders
feeding behavior
Eating disorder
behavior, nos
mass screening
Eating behavior disorders
Feeding and Eating Disorders
pregnancy, nos
Pregnant People
Eating behavior disorders

---
https://dumas.ccsd.cnrs.fr/dumas-04036946
2023
France
evaluation studies as topic
Physicians
french
screening
questionnaires
France
behavior, nos
general practice
mass screening
France
registries
spouse abuse
France
Violencia
france
France

---
https://dumas.ccsd.cnrs.fr/dumas-04087820
2023
France
research design
primary health care
Violencia
mass screening
nursing
battered women
screening
primary health care
principal
Researches
research
women

---
https://www.inspq.qc.ca/publications/3318
2023
Canada
review of literature
with distribution
population
human immunodeficiency virus, nos
Self-Testing
Direct-To-Consumer Screening and Testing
HIV
demography

---
https://www.sfed.org/wp-content/uploads/2023/05/Dilatation-bougies-fa0.pdf
2023
false
false
false
France
patient education handout
dilatation, nos
endoscopy, nos
achievement
endoscopy
Endoscopy
endoscope, nos
endoscopes
dilatation

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1307
2023
France
scientific and technical information
contraindication to
west nile virus
waiting lists
measures
Contraindications
seasons
postal service
mass screening
motivation, nos
virus, nos
transitory
mail
research report
Motivation
weights and measures
Virus
screening
Viruses
Motivation
albumin/globulin ratio
decreased motivation
motivation

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/principes-et-criteres-de-selection-des-genes-pour-le-diagnostic-moleculaire-des-maladies-en-genetique-constitutionnelle-par-sequencage-de-nouvelle-generation-sng.html
2023
Canada
technical report
Molecular genetics
policy
disease
family characteristics
generations
genetics, molecular
genetic selection
Genetic disease
principle-based ethics
nasogastric tube
pathology, molecular
Diseases
no diagnosis
selection, genetic
selection criteria
hereditary disease, nos
sequence analysis
genetic diseases, inborn
diagnosis
Molecular genetics
genes
patient selection
sequence determinations

---
https://www.infectiologie.com/UserFiles/File/spilf/recos/spilf-groupe-recos-idv-2023.pptx
2023
France
scientific and technical information
adulthood
Adult
infectious disease, nos
no diagnosis
Infections
Adult
diagnosis
vertebra, nos
adult
Infectious disease

---
https://conseil-scientifique.public.lu/fr/publications/geriatrie/depistage-des-fragilites-des-personnes-agees-de-plus-de-75-ans-consultant-dans-un-service-d-urgence.html
2023
Luxembourg
public health guidelines
aged
Frailty
consultants
elderly person, nos
screening
mass screening
emergencies
aged, 80 and over
homemaker services
fragility, nos
frail elderly
emergency service, hospital

---
https://www.cancer.fr/catalogue-des-publications/leucemie-lymphoide-chronique-du-diagnostic-au-suivi
https://www.cancer.fr/professionnels-de-sante/recommandations-et-aide-a-la-pratique/outils-pour-la-pratique-des-medecins-generalistes/outils-par-localisation-de-cancer/leucemie-lymphoide-chronique
2023
false
false
false
France
guideline
diagnosis
Chronic lymphocytic leukemia
leukaemia
leukemia, lymphocytic, chronic, B-Cell
chronic lymphocytic leukemia
leukemia, lymphoid
no diagnosis
aftercare

---
https://www.has-sante.fr/jcms/p_3312530/fr/diagnostic-et-prise-en-charge-des-patients-adultes-avec-un-syndrome-post-reanimation-pics-et-de-leur-entourage
2023
France
practice guideline
adulthood
charge association
resuscitation
no diagnosis
case management
diagnosis
CHARGE syndrome
Adult
Propping Zerres syndrome
Adult
has patient
adult
CHARGE syndrome
propping zerres syndrome

---
https://www.has-sante.fr/jcms/p_3444489/fr/interet-des-tests-rapides-d-orientation-diagnostique-trod-antigeniques-covid/grippe-et-covid/grippe/vrs-en-ville
2023
France
health technology assessment
blood group antigen be a
blood group antigen cl a
blood group antigen n a
blood group antigen c
blood group antigen mcc a
blood group antigen in a
blood group antigen at a
blood group antigen wd a
blood group antigen rg a
blood group antigen lan
blood group antigen sw a
blood group antigen a.m.
blood group antigen lw a
blood group antigen ny a
blood group antigen fy a
blood group antigen an a
blood group antigen en ats
blood group antigen en afs
blood group antigen le bh
blood group antigen a1 le b
blood group antigen en afr
blood group antigen ht a
blood group antigen dh a
blood group antigen er a
blood group antigen ol a
blood group antigen ri a
blood group antigen tr a
blood group antigen m'
blood group antigen a.m.
blood group antigen js a
blood group antigen sk a
blood group antigen th a
blood group antigen rd a
blood group antigen a2
blood group antigen a3
orientation
blood group antigen mi a
blood group antigen sf a
blood group antigen jo a
blood group antigen u1a
blood group antigen je a
blood group antigen wk a
blood group antigen yt a
blood group antigen ls a
blood group antigen c
blood group antigen go a
blood group antigen rh42
blood group antigen vr
blood group antigen wr a
blood group antigen cs a
blood group antigen a x
blood group antigen r1a
blood group antigen a1 le d
blood group antigen sd a
blood group antigen jc a
blood group antigen chr a
blood group antigen sc2
blood group antigen le a
blood group antigen fr a
blood group antigen le b
blood group antigen dr a
blood group antigen jn a
blood group antigen le x
blood group antigen a3b
blood group antigen es a
blood group antigen m a
blood group antigen rh a
blood group antigen bx a
blood group antigen rb a
Antigens
blood group antigen ok a
antigens
blood group antigen xg a
blood group antigen ch a
blood group antigen yk a
blood group antigen cr3
blood group antigen bp a
blood group antigen jk a
blood group antigen mo a
blood group antigen or a
blood group antigen pt a
blood group antigen gy a
diagnostic tests
reagent kits, diagnostic
blood group antigen 'n'
blood group antigen jr a
blood group antigen do a
antigen, nos
blood group antigen st a
blood group antigen mt a
blood group antigen hg a
blood group antigen to a
blood group antigen vg a
blood group antigen lu a
blood group antigen kp a
blood group antigen au a
blood group antigen pr a
blood group antigen lw b
blood group antigen kn a
blood group antigen a2b
blood group antigen co a
blood group antigen re a
blood group antigen le c
blood group antigen le s
blood group antigen di a
blood group antigen zt a
blood group antigen li a
blood group antigen pr a
blood group antigen yh a
blood group antigen tj a
blood group antigen en akt
blood group antigen le ns
working diagnosis
blood group antigen s1a
blood group antigen le d
blood group antigen nijhuis
blood group antigen a1b
blood group antigen tg a
blood group antigen le bl
blood group antigen os a
blood group antigen bg a
blood group antigen m1a

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/protocole-medical-national-infections-urinaires.html
2023
Canada
review of literature
elderly person, nos
weights and measures
Urinary tract infection
measures
pharmacology
cystitis, nos
symptom, nos
signs and symptoms
urinary tract infections
Symptom
administration, oral
diagnosis
cystitis
Pyelonephritis
aged, 80 and over
pharmacologist
pyelonephritis, nos
suggestion
aged
pyelonephritis
intention
urinary tract infections
Cystitis
urinary tract infectious disease, nos

---
https://www.reseau-naissance.fr/medias/2022/12/RSN-PRO_001-Hypoglycemie-du-nouveau-ne-mmol_l.pdf
https://www.reseau-naissance.fr/medias/2022/12/RSN-PRO_002-Hypoglycemie-du-nouveau-ne-gr_l.pdf
2023
France
guideline
no diagnosis
diagnosis
Hypoglycemia
hospitals, maternity
hypoglycaemia
hypoglycemia
motherhood
patient care management
infant, newborn
neonatal hypoglycemia

---
https://conseil-scientifique.public.lu/fr/publications/prevention-medecine-generale/la-prevention-et-le-depistage-chez-les-adolescents-et-les-adultes-version-pour-les-patients-2023.html
2023
France
popular works
adulthood
adolescent
adolescence
Adult
Adult
mass screening
Adolescent
Adolescent
patients
has patient
adult
screening

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-6-juin-2023/recours-accru-prep-entraine-diminution-diagnostics-vih.html
2023
Canada
journal article
Pre-Exposure Prophylaxis
human immunodeficiency virus, nos
temefos
no diagnosis
prophylactic treatment, nos
coitus
men
HIV
diagnosis
canada

---
https://ansm.sante.fr/informations-de-securite/bricanyl-turbuhaler-et-bricanyl-nebuliseur-information-importante-a-transmettre-aux-patients
2023
false
false
false
France
French
guidelines for drug use
-
terbutaline
administration, inhalation
bronchodilator agents
adrenergic beta-2 receptor agonists
terbutaline
pharmacovigilance note

---
http://beh.santepubliquefrance.fr/beh/2023/14/2023_14_2.html
2023
France
journal article
Program
Organization
breast neoplasms
screening for cancer
France
Organization
organization
France
breast cancer
cancer screening
France
early detection of cancer
french
France
Breast cancer
mass screening
france

---
https://minerva-ebp.be/FR/Article/2329
2023
Belgium
critical appraisal or critical reading
urinary tract infections
urinary tract infections
pyuria
Urinary tract infection
urinary tract infectious disease, nos
pyuria
no diagnosis
diagnosis

---
https://publications.msss.gouv.qc.ca/msss/document-003609/
2023
Canada
popular works
risk
caregivers
detective
persons
Safety
messenger
security measures
homemaker services
early diagnosis
risk assessment

---
https://www.has-sante.fr/jcms/p_3454355/fr/prohance-gadoteridol-produit-de-contraste-en-irm
2023
false
false
false
France
French
insurance, health, reimbursement
contrast media
evaluation of the transparency committee
gadoteridol
gadoteridol
magnetic resonance imaging
adult
child
spinal cord diseases
spinal diseases
whole body imaging
Magnetic resonance imaging of head and spine with contrast (procedure)

---
http://beh.santepubliquefrance.fr/beh/2023/15-16/2023_15-16_1.html
2023
France
journal article
Hepatitis
hepatitis C
France
screening
detective
France
mass screening
France
viral hepatitis c
type b viral hepatitis
hepatitis B
france
France
french

---
http://beh.santepubliquefrance.fr/beh/2023/15-16/2023_15-16_3.html
2023
France
journal article
France
hepatitis C
french
pandemics
screening
public policy
Hepatitis
france
viral hepatitis c
COVID-19
France
mass screening
France
France

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/cartographie-optique-du-genome-diagnostic-et-stratification-pronostique-des-hemopathies-malignes.html
2023
Canada
technical report
genome mapping
chromosome mapping
hematologic diseases
Malignant hemopathy
hematologic neoplasms
genome, nos
Hematologic and hematopoietic diseases
Optics
no diagnosis
Hemopathies
diagnosis

---
https://www.santepubliquefrance.fr/regions/antilles/documents/enquetes-etudes/2023/evaluation-de-la-performance-du-programme-de-depistage-organise-du-cancer-du-sein-resultats-et-evolution-des-indicateurs-de-performance-dans-les
2023
France
technical report
indication of
breast neoplasms
suggestive of
Organization
screening for cancer
early detection of cancer
Outcome Assessment, Health Care
breast cancer
resulting in
cancer screening
Organization
organization
program evaluation
Breast cancer
mass screening
oceans and seas
outcome measures
Regions

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1323
2023
France
public health guidelines
Systematics
Systematics
gametes
cytomegalovirus, nos
embryonic structures
cytomegalovirus
germ cells
Systematics
judgment
embryo
Taxonomy
mass screening
tissue donors
donors

---
https://www.cfp.ca/content/69/8/e165
2023
Canada
journal article
fracture, nos
screening
mass screening
osteoporotic fractures
Fracture
primary prevention
principal

---
https://www.usherbrooke.ca/baladocritique/archives/episode-56-recommandations-sur-le-depistage-pour-la-prevention-primaire-des-fractures-de-fragilisation-lignes-directrices-du-gecssp-2023
2023
false
false
false
Canada
sound
principal
mass screening
primary prevention
fracture, nos
Fracture
osteoporotic fractures
health planning guidelines
screening
episode of

---
https://www.cancer.fr/catalogue-des-publications/bande-dessinee-en-facile-a-lire-et-a-comprendre-falc-sur-le-depistage-des-cancers-du-sein-28-pages-a4
2023
false
false
false
France
patient education handout
screening
support, nos
instruction
mass screening
teaching
breast

---
Xylazine Test Strips for Drug Checking
https://www.cadth.ca/fr/les-bandelettes-reactives-pour-deceler-la-xylazine-dans-les-drogues
2023
false
false
false
Canada
French
health technology assessment
reagent strips
xylazine
Illicit Drugs

---
https://dumas.ccsd.cnrs.fr/dumas-03999150
2023
France
dissertations, academic
Twelve
Algeria
Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain
screening
Lowest
Low Calcium Level
Medication
Screening for Skin Cancer
Lower
Value Below Reference Range
medicine
IPSS Risk Category Low
Low LDH Level
Serum CEA Level Low
Screening Study
Bottom
Low Mitosis-Karyorrhexis Index
GDC Biospecimen Anatomic Site Terminology
mass screening
general practitioners
Malignant Germ Cell International Collaborative Risk Classification, Low
Serum CA 19-9 Low
skin, nos
IPSS-R Risk Category Low
Low Level
qualitative research

---
https://dumas.ccsd.cnrs.fr/dumas-04137408
2023
France
dissertations, academic
mass screening
behavior, addictive
cost of illness
Burden
disease management
Addiction
Near
caregivers
dependent drug abuse
disease, nos
Review
Charge
screening
Disease Screening
Caregiver Burden
Nearest
narration

---
https://dumas.ccsd.cnrs.fr/dumas-04171805
2023
France
dissertations, academic
Tool
evaluation studies as topic
Substance Screening
Assessment
Biomedicine
general practice
hypertension
pediatrics
Screening Study
Pediatricians
Hypertension
screening
Trial Screening
Cancer Screening
Scientific Equipment
tool, nos
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
pediatrician
Physical Examination
Site Screening
Assessment
hypertensive disease, nos
Eligibility Determination
Family Practice
Evaluation
Pediatrics
Genetic Screening
mass screening
Last Screening

---
https://ged.univ-rennes1.fr/nuxeo/site/esupversions/e411ab5a-5329-4d5d-84af-cff45caad3b2
2023
France
dissertations, academic
Centi
measures
central
Hub Device
screening
Preventive Intervention
Prevention
COVID-19 Infection
mass screening
COVID-19
weights and measures
qualitative research
Prevention Study
Screening Study
Center

---
https://pepite-depot.univ-lille.fr/LIBRE/Th_Medecine/2023/2023ULILM009.pdf
2023
France
dissertations, academic
infarction
Patient
patients
has patient
Feasibility
Programming Parameter
Atrial
Population Parameter
prognosis, nos
prognosis
infarct, nos
Infarction
mechanics
Mechanism

---
https://www.snfge.org/actualites/aucune-utilite-clinique-tests-sanguins-depistage-dune-allergie-alimentaire-dosage
2023
false
false
false
France
popular works
Blood Screening
immunoglobulin measurement, nos
IgG
Clinical Data
immunoglobulin igg, nos
immunoglobulins
hospitals, proprietary
food, nos
Ambulatory Care Facility
screening
allergy testing, nos
Useful
Food
gastrointestinal food allergy, nos
Immunoglobulin Measurement
Hematology Test
Clinical Batch
With Food
mass screening
eating, nos
Clinical Lot
immunoglobulin G
food
food hypersensitivity
Food Allergy

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pylclari
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluorine F 18 Piflufolastat
Fluorine F 18 Piflufolastat
piflufolastat (18F)
drug approval
europe
adult
prostatic neoplasms
Positron-Emission tomography
FOLH1 protein, human
neoplasm recurrence, local
Presence of direct invasion by primary malignant neoplasm of prostate to periprostatic tissue (observable entity)
neoplasm staging
fluorine radioisotopes
fluorine radioisotopes
radiopharmaceuticals
product surveillance, postmarketing
injections, intravenous
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3459565/fr/conduite-diagnostique-devant-une-epaule-douloureuse-non-traumatique-de-l-adulte-et-prise-en-charge-des-tendinopathies-de-la-coiffe-des-rotateurs
2023
France
guideline
Rotator Cuff
Tool
tool, nos
Shoulder Joint
Scientific Equipment
shoulder
Undiagnosed
diagnosis
adulthood
injury, nos
Injury
professional practice
leadership
Painful
Enhance
Hibiscus sabdariffa Flower
Driving
Charge
pain, nos
Shoulder
patient care management
Improved
adult
tendinopathy
Legal Adult
Professional Practice
Trifolium pratense Flower
shoulder pain
rotator cuff

---
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/PNDS_SNI_Adulte_2023.pdf
2023
France
practice guideline
adulthood
propping zerres syndrome
no diagnosis
nephrotic syndrome
adult
unknown (origin)
Clinical Study Protocol
Date of Diagnosis
Legal Adult
diagnosis
On Study
How True Feel Carefree Right Now
nursing
Idiopathic Nephrotic Syndrome
Diagnosis Study
Propping Zerres syndrome
nephrotic syndrome, nos
Healthcare
Care
Healthcare Activity
Diagnosis Code

---
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2023-49/issue-9-september-2023/ccdrv49i09a04af-fra.pdf
2023
Canada
scientific and technical information
Genetic Screening
Last Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
gonorrhea
pregnancy
Substance Screening
chlamydia, nos
Pregnancy
gonorrhea, nos
Cancer Screening
Site Screening
health planning guidelines
Gonorrhea
chlamydia
Working Kelpie
Screening Study
Eligibility Determination
screening
canada
Chlamydia
pregnancy, nos
Chlamydial Infection
Chlamydia Measurement
Trial Screening
mass screening
Pregnant

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/dispositif-optunemc-pour-le-traitement-des-patients-adultes-atteints-dun-glioblastome-nouvellement-diagnostique.html
2023
Canada
health technology assessment
glioblastoma, nos
Therapy Object
During Treatment
Panel Device
Magazine Device
Treatment
adulthood
Newly Diagnosed
NovoTTF-100A Device
Set, Psychology
patients
diagnosis
adult
Biomaterial Treatment
Treatment Study
Cup Device
disease
Patient
device, nos
No Treatment for Diabetes
Counter Device
equipment and supplies
Adult Glioblastoma
Treat
devices
has patient
Smoking Device
glioblastoma
GDC Treatment Frequency Terminology
Bearing Device
Treatment Epoch
On Treatment

---
https://www.ema.europa.eu/en/medicines/human/EPAR/locametz
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Gozetotide
Gozetotide
drug approval
europe
Positron-Emission tomography
diagnostic uses of chemicals
gallium 68 PSMA-11
prostatic neoplasms
adult
gallium radioisotopes
radiopharmaceuticals
injections, intravenous
FOLH1 protein, human
gallium (68Ga) gozetotide
product surveillance, postmarketing
Radiopharmaceutical Preparation Kit Dosage Form
pregnancy
breast feeding

---
https://www.cfp.ca/content/69/1/e8
2023
Canada
journal article
Parkinson disease
Diseases
parkinson disease
no diagnosis
parkinson's disease, nos
diagnosis

---
https://www.louvainmedical.be/fr/article/diagnostic-par-limage-une-bien-drole-de-piqure
2023
Belgium
journal article
stings
diagnosis
bites and stings
no diagnosis

---
https://www.has-sante.fr/jcms/p_3408799/fr/rapiscan-regadenoson-monohydrate-imagerie-de-perfusion-myocardique
2023
false
false
false
France
insurance, health, reimbursement
diagnostic uses of chemicals
injections, intravenous
adult
Cardiovascular stress test using pharmacologic stress agent (procedure)
evaluation of the transparency committee
regadenoson
myocardial perfusion imaging

---
https://dumas.ccsd.cnrs.fr/dumas-03958257
2023
France
dissertations, academic
data collection
primary aldosteronism
Physicians
detective
secondary aldosteronism, nos
Hypertension
hyperaldosteronism
hypertension
general practice
secondary
secondary diagnosis
secondary hypertension, nos
Practice
Hyperaldosteronism
diagnosis

---
https://publication-theses.unistra.fr/public/theses_exercice/MED/2022/2022_CHEVRIAUX_Amandine.pdf
2023
France
dissertations, academic
Literature
primary health care
principal
primary prevention
primary health care
child, nos
child, gifted
consultants
tool, nos
Child
referral and consultation
Child
Early Intervention, Educational
review literature as topic
early diagnosis
Child
early medical intervention
nursing
due to
Child

---
https://www.cfp.ca/content/69/2/e33
2023
Canada
journal article
screening
Medical Overuse
Overdiagnosis
mass screening
diagnosis
no diagnosis

---
https://sfar.org/positionnement-de-la-sfar-sur-la-strategie-de-depistage-covid-19-avant-une-chirurgie-programmee-en-periode-de-circulation-du-variant-omicron-de-sars-cov-2/
2023
France
scientific and technical information
screening
Surgery
mass screening
operative procedure, nos
SARS-CoV-2
Program
COVID-19
general surgery
Periodical

---
https://dumas.ccsd.cnrs.fr/dumas-03997433
2023
France
dissertations, academic
autistic disorder
Autism
no diagnosis
autistic thinking
physicians, primary care
diagnosis
Physicians

---
https://dumas.ccsd.cnrs.fr/dumas-03997598
2023
France
dissertations, academic
screening
patient care management
Caregiver Burden
tool, nos
Physicians
general practice
stalking
mass screening

---
https://publications.msss.gouv.qc.ca/msss/document-000282/
2023
false
false
false
Canada
patient education handout
urinary tract, nos
infant, newborn
screening
neonatal screening
newborn, nos
infant, newborn
mass screening

---
https://www.snfge.org/tncd/carcinome-hepatocellulaire-cancer-primitif-du-foie
2023
false
false
France
French
hemostatics
antineoplastic agents, hormonal
vasoconstrictor agents
liver cirrhosis
diagnostic imaging
neoplasm staging
carcinoma, hepatocellular
liver cirrhosis
carcinoma, hepatocellular
incidence
liver cirrhosis
carcinoma, hepatocellular
biopsy, needle
liver
severity of illness index
carcinoma, hepatocellular
liver cirrhosis
liver transplantation
carcinoma, hepatocellular
hepatectomy
chemoembolization, therapeutic
octreotide
carcinoma, hepatocellular
carcinoma, hepatocellular
liver cirrhosis
liver cirrhosis
continuity of patient care
mass screening
carcinoma, hepatocellular
antidiarrheals
practice guideline
liver cirrhosis
carcinoma, hepatocellular

---
https://www.has-sante.fr/portail/jcms/c_2891090/fr/methodes-de-recherche-d-un-deficit-en-dihydropyrimidine-deshydrogenase-visant-a-prevenir-certaines-toxicites-severes-associees-aux-traitements-incluant-une-fluoropyrimidine-5-fluorouracile-ou-capecitabine
https://www.cancer.fr/catalogue-des-publications/recherche-de-deficit-en-dihydropyrimidine-deshydrogenase-en-vue-de-prevenir-certaines-toxicites-severes-survenant-sous-traitement-comportant-des-fl
2023
false
false
false
France
mass screening
Capecitabine
fluorouracil
uracil
poisoning
health technology assessment
dihydropyrimidine dehydrogenase deficiency

---
https://dumas.ccsd.cnrs.fr/dumas-04348644
2023
France
dissertations, academic
general practice
mass screening
proband
screening

---
https://lns.lu/
false
Luxembourg
French
establishment, institution, organization
laboratories
clinical laboratory services
microbiology
forensic medicine
neoplasms

---
https://iris.who.int/bitstream/handle/10665/375917/9789240079519-fre.pdf?sequence=1&isAllowed=y
2023
Switzerland
technical report
Profile
Laboratory Procedure
Product Part
smallpox
smallpox, nos
diagnosis
Diagnosis Code
no diagnosis
Pharmacologic Substance
Mpox, Monkeypox
Target Lesion Identification
Date of Diagnosis
Target
Diagnosis Study
Smallpox
Has_Target

---
https://dumas.ccsd.cnrs.fr/dumas-04291031
2023
France
dissertations, academic
uncertainty
general practitioners
teleconsultation
Diagnosis
Management
Family Practice
Management Occupations
Primary Care Provider
Have Not Been Diagnosed
remote consultation
general physician, nos
diagnosis
general practice
Biomedicine
Uncertain

---
https://dumas.ccsd.cnrs.fr/dumas-04413875
2023
France
dissertations, academic
depression, postpartum
Binding
Woman
tool use behavior
female
perinatal state, nos
child
reactive attachment disorder
Fastener Device
Site Screening
Fix
women
Female Phenotype
Last Screening
Childhood Depression
mother, nos
Scientific Equipment
depressive disorder
mass screening
Wife
child, nos
Cancer Screening
depression
Substance Screening
Use
Perinatal Depression
Tool
Screening Study
Genetic Screening
Trial Screening
psychometrics
Phenylmercuric Acetate
Oman
screening
tool, nos
Eligibility Determination
depression, nos
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening

---
https://www.coreb.infectiologie.com/UserFiles/File/monkeypox/20230427-mkppatient.pdf
2023
France
popular works
Veterinary Patient
Diagnosis
has patient
patients
diagnosis
Monkeypox
Mpox, Monkeypox
Have Not Been Diagnosed
monkeypox

---
https://orscreainormandie.org/nos_derniers_travaux/diagnostic-regional-sante-environnement-contribution-a-lactualisation-menee-dans-le-cadre-du-prse4/
2023
France
scientific and technical information
Daur Chinese
Deoxyuridine
Disease or Disorder
Local-Regional
Device-In-Use Domain
no diagnosis
Surrounding
Date of Diagnosis
Regional Disease
diagnosis
Local
Diagnosis Code
Diagnosis Study
Approximate
environmental health
Due
Less Than or Equal To
LE, Rat Strain
Environmental

---
https://dumas.ccsd.cnrs.fr/dumas-04632417
2023
France
dissertations, academic
review literature as topic
Charge
patient care management
Impact
endometriosis
delayed diagnosis
endometriosis, nos
classification
Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement
Reviewing
Delay to Diagnosis due to Device
Endometriosis
Systematic Review
no diagnosis

---
https://www.has-sante.fr/jcms/p_3466023/fr/evaluation-de-plusieurs-actes-relatifs-au-depistage-cible-annuel-de-la-maladie-renale-chronique-chez-l-adulte
2023
France
health technology assessment
Evaluable Disease
screening
Legal Adult
Chronic Renal Failure
kidney diseases
Assay Target Antigen
Annual Screening
renal insufficiency, chronic
mass screening
Chronic Kidney Disease, CTCAE
symptom assessment
kidney disease, nos
adult disease, nos
adult
chronic disease, nos
chronic disease

---
https://ansm.sante.fr/actualites/tests-rapides-de-depistage-des-angines-a-streptocoque-trod-informations-pratiques-a-destination-des-pharmaciens-1
2023
false
false
false
France
French
technical report
reagent kits, diagnostic
pharyngitis
streptococcal infections
Streptococcal Pharyngitis

---
https://kce.fgov.be/fr/publications/diagnostic-et-prise-en-charge-de-la-gonorrhee-et-de-la-syphilis
2023
Belgium
technical report
french abstract
Syphilis
Diagnosis Code
Date of Diagnosis
gonorrhea
Charge
diagnosis
Gonorrhea
Diagnosis Study
no diagnosis
syphilis, nos
gonorrhea, nos
patient care management
syphilis

---
https://www.academie-medecine.fr/avis-conjoint-des-academies-nationales-de-medecine-et-de-pharmacie-sur-lerrance-diagnostique-dans-les-maladies-rares/
2023
France
scientific and technical information
judgment
pharmacy
Have Not Been Diagnosed
Diagnosis
Academia
Medication
wandering behavior
Width
academies and institutes
rare diseases
spouses
medicine
disease, nos
Rare Disorder
Neither Agree or Disagree
Pharmacy
Spouse
academies
diagnosis

---
https://www.sf2h.net/k-stock/data/uploads/2023/03/Avis-SFN-du-6-mars-2023-diagnostic-traitement-et-depistage-neonatologie.pdf
2023
France
scientific and technical information
organization and administration
Diagnostic Method
Infections
Attention Concentration
Antibiotic Therapy
Infection
judgment
indicators and reagents
neonatology
Antibiotic
GDC Method of Diagnosis Terminology
diagnosis
infectious disease, nos
no diagnosis
suggestive of
antibiotic therapy
Neither Agree or Disagree
Relative Value
Neonatology
indication of
Management
protestantism
Sector

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.